JADE-002

N/A

Report date: 2026/05/27 15:15:14

Base Information

Drug NameJADE-002
Drug Alias NameAfucosylated monoclonal antibody (Paragon Therapeutics)JADE-002JADE002PR041PR-041 +[7
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionB-cell activating factor receptor modulators
TargetsB-cell activating factor receptor
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkraine
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesParagon Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A